Jounce Therapeutics Inc
Change company Symbol lookup
Select an option...
JNCE Jounce Therapeutics Inc
KO Coca-Cola Co
TRV Travelers Companies Inc
CSCO Cisco Systems Inc
CVX Chevron Corp
RF Regions Financial Corp
THG Hanover Insurance Group Inc
USB U.S. Bancorp
WFC Wells Fargo & Co
BAC Bank of America Corp
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. The Company’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates Inducible T cell CO-Stimulator (ICOS) and is in a Phase II trial.

Postmarket

Last Trade
Delayed
$8.74
0.01 (0.11%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$8.73
Day's Change
-0.19 (-2.13%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
9.10
Day's Low
8.62
Volume
(Light)
Volume:
561,418

10-day average volume:
1,635,311
561,418
  • Prev Close
    8.92
  • Today's Open
    9.07
  • Day's Range
    8.62-9.10
  • Avg Vol (10-day)
    1.6M
  • Last (time)
    4:00p ET 09/22/20
  • Last (size)
    3
  • 52-Wk Range
    2.79 - 11.72
    LowHigh
  • (10/04/19 - 09/15/20)
    25.51%
  • 107.6%
  • Market Cap
    298.7M
  • Shares Outstanding
    34.2M
  • 0.62
  • 14.48x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 75.64
  • (% of float 08/31/20)
    7.00

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.